Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa)

Curcuma longa
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

Curcumin C3 Reduct® is a tetrahydrocurcuminoid (THC) ingredient from Sabinsa, the colorless metabolite form of turmeric's curcuminoids. Because the body normally converts curcumin into THC, delivering it pre-converted aims for better absorption and a strong, long-lasting antioxidant effect.

Studied Dose Commonly around 150 to 600 mg per day.
Active Compound Tetrahydrocurcuminoids (THC), the colorless hydrogenated metabolites of turmeric curcuminoids.

Benefits

Antioxidant defense

Tetrahydrocurcuminoids are described as cascading antioxidants, providing strong and longer-lasting antioxidant activity than parent curcumin.

Anti-inflammatory support

As curcuminoid metabolites, THCs support a healthy inflammatory response; curcumin/turmeric reduces inflammation markers in meta-analysis.

Better absorption and stability

THC is colorless, stable, and pre-converted, designed for better absorption than ordinary curcumin.

Mechanism of action

1

Cascading antioxidant action

Tetrahydrocurcuminoids quench free radicals over a longer period than standard antioxidants, supporting cellular protection.

2

Curcuminoid signaling

As curcumin metabolites, THCs act on inflammatory and antioxidant pathways such as NF-kB and Nrf2.

Clinical trials

1
Curcuminoids and Inflammation — Meta-Analysis
PubMed

GRADE-assessed systematic review and dose-response meta-analysis of curcumin/turmeric supplementation. (Dehzad et al. 2023, Cytokine)

Adults across multiple trials.

Curcumin/turmeric supplementation reduced inflammation and oxidative-stress markers; C3 Reduct delivers these curcuminoids as their active metabolites.

Side effects and drug interactions

Common Potential side effects

GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses.
Mild digestive upset is occasionally reported.
Discontinue if any unusual reaction occurs.

Important Drug interactions

Anticoagulants — curcuminoids may have a mild additive effect; monitor.
Gallbladder disease — use caution, as curcuminoids stimulate bile.
Tell your doctor before surgery if taking high doses.

Frequently asked questions about Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa)

What is Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa)?

Curcumin C3 Reduct® is a tetrahydrocurcuminoid (THC) ingredient from Sabinsa, the colorless metabolite form of turmeric's curcuminoids. Because the body normally converts curcumin into THC, delivering it pre-converted aims for better absorption and a strong, long-lasting antioxidant effect.

What is the recommended dosage of Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa)?

The clinically studied dose for Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa) is Commonly around 150 to 600 mg per day.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa) used for?

Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa) is studied for antioxidant defense, anti-inflammatory support, better absorption and stability. Tetrahydrocurcuminoids are described as cascading antioxidants, providing strong and longer-lasting antioxidant activity than parent curcumin.

Are there side effects from taking Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa)?

Reported potential side effects may include: GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses. Mild digestive upset is occasionally reported. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Is Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa) safe to take?

Whether Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa) is safe depends on the dose, your overall health, and any medications you take. At studied doses, reported side effects can include: GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses. It may also interact with certain medications. Curcumin C3 Reduct® (Tetrahydrocurcuminoids — Sabinsa) is not suitable for everyone — consult a healthcare provider before use if you are pregnant or breastfeeding, have a medical condition, or take prescription medications.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Dehzad MJ, Ghalandari H, Nouri M, et al. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Cytokine. 2023;164:156144..PubMedUsed to support: Meta-analysis supporting anti-inflammatory benefit of curcuminoids (delivered as metabolites in C3 Reduct).